Genprex, Inc. Common Stock GNPX
Key Stats
- Today's Range
- $3.31 – $3.44
- 50-Day Range
- $3.31 – $15.60
- 52-Week Range
- $3.31 – $1210.00
- Volume
- 22K shs
- Average Volume
- 333K shs
- Market Cap
- $2.81 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.19
- Price / Sales
- —
Short Interest
- Short Interest
- 2.89%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-16,498,565
- Net Margin
- —
- Return on Equity
- -111.51%
- Debt-to-Equity
- —
About Genprex, Inc. Common Stock
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Related Stocks
Compare head-to-head: GNPX vs LLY·GNPX vs JNJ·GNPX vs ABBV·GNPX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.